Related Experiment Video
Updated: Feb 26, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Wearable cardioverter defibrillator: Bridge or alternative to implantation?
Jeremie Barraud1, Jennifer Cautela1, Morgane Orabona1
1Jeremie Barraud, Jennifer Cautela, Morgane Orabona, Johan Pinto, Olivier Missenard, Marc Laine, Franck Thuny, Franck Paganelli, Laurent Bonello, Michael Peyrol, Department of Cardiology, Aix-Marseille University, Assistance Publique - Hôpitaux de Marseille, Nord Hospital, 13015 Marseille, France.
Insights
The wearable cardioverter defibrillator (WCD) offers an alternative for preventing sudden cardiac death (SCD) in high-risk patients, especially when implantable cardioverter-defibrillators (ICDs) are not suitable.
Area of Science:
- Cardiology
- Medical Devices
- Electrophysiology
Background:
- Implantable cardioverter-defibrillators (ICDs) prevent sudden cardiac death (SCD) in high-risk patients.
- ICDs are not suitable for patients with transient risks or temporary contraindications.
Purpose of the Study:
- To review the clinical uses and benefits of the wearable cardioverter defibrillator (WCD).
- To describe the technical aspects, limitations, and future perspectives of WCDs.
Main Methods:
- Literature review of current clinical applications of WCDs.
- Analysis of WCD technical features and patient outcomes.
Main Results:
- WCDs are increasingly used for SCD prevention in patients awaiting ICD implantation.
- WCDs are effective for managing transient high risks of ventricular arrhythmia.
Conclusions:
- WCDs provide a valuable, non-invasive option for SCD prevention in specific patient populations.
- Further research into WCD limitations and long-term benefits is warranted.
Abstract:
The implantable cardioverter-defibrillator (ICD) is effective to prevent sudden cardiac death (SCD) in selected patients with heart disease known to be at high risk for ventricular arrhythmia. Nevertheless, this invasive and definitive therapy is not indicated in patients with potentially transient or reversible causes of sudden death, or in patients with temporary contra-indication for ICD placement. The wearable cardioverter defibrillator (WCD) is increasingly used for SCD prevention both in patients awaiting ICD implantation or with an estimated high risk of ventricular arrhythmia though to be transient. We conducted a review of current clinical uses and benefits of the WCD, and described its technical aspects, limitations and perspectives.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
04:24A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation III: AED Use
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...